Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P1588

   Activity of ceftaroline and comparators against Streptococcus pneumoniae from multiple specimen sources in the European region 2012: assessing worldwide antimicrobial resistance evaluation (AWARE) programme

   Doug Biedenbach, Schaumburg, United States

   Hoban, D.(1)*; Badal, R.(1); Biedenbach, D.(1); Hackel, M.(1); Bouchillon, S.(1); Ambler, J.(2);

   13 May 2014

   Session: Resistance surveillance: Gram-positives and others

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

2. P1593

   Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in the European region – AWARE surveillance 2012

   Doug Biedenbach, Schaumburg, United States

   Badal, R.(1)*; Hoban, D.(1); Hackel, M.(1); Bouchillon, S.(1); Biedenbach, D.(1); Hawser, S.(2); Iaconis, J.(3);

   13 May 2014

   Session: Resistance surveillance: Gram-positives and others

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

3. P1596

   In vitro activity of antimicrobial agents tested against anaerobic pathogens from the European TEST programme during 2012-2013

   Doug Biedenbach, Schaumburg, United States

   Biedenbach, D.(1)*; Hackel, M.(1); Morrissey, I.(2); Bouchillon, S.(1); Leister-Tebbe, H.(3);

   13 May 2014

   Session: Resistance surveillance: Gram-positives and others

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

4. P1615

   Trends in resistance rates in Enterobacteriaceae collected globally from extended care facilities (TEST 2004-2012)

   Doug Biedenbach, Schaumburg, United States

   Hawser, S.(1)*; Badal, R.(2); Biedenbach, D.(2); Morrissey, I.(1); Leister-Tebbe, H.(3);

   13 May 2014

   Session: Controling infections in long-term care facilities

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

5. P1479

   Contemporary staphylococcal resistance rates observed in European countries using data derived from TEST programme (2010-2013)

   Doug Biedenbach, Schaumburg, United States

   Johnson, B.(1)*; Hackel, M.(1); Morrissey, I.(2); Biedenbach, D.(1); Bouchillon, S.(1); Johnson, J.(1);

   13 May 2014

   Session: Epidemiology and clinical impact of S. aureus resistance

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

6. P1778

   Tigecycline activity against enteric pathogens resistant to amikacin as determined from TEST program analysis over ten years - TEST 2013

   Doug Biedenbach, Schaumburg, United States

   Bouchillon, S.(1)*; Biedenbach, D.(1); Hackel, M.(1); Badal, R.(1); Hawser, S.(2); Leister-Tebbe, H.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

7. P1781

   Activity of ceftazidime-avibactam and comparators versus characterised ESBL-positive Gram-negative bacteria isolated in the European region: 2012 programme

   Doug Biedenbach, Schaumburg, United States

   Kazmierczak, K.(1)*; Hickman, S.(1); Hackel, M.(1); Badal, R.(1); Biedenbach, D.(1); Morrissey, I.(2); Bouchillon, S.(1); Stone, G.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

8. P1782

   Activity of ceftazidime-avibactam versus Pseudomonas aeruginosa, including multiple-drug resistant isolates in Europe - the 2012 INFORM programme

   Doug Biedenbach, Schaumburg, United States

   Bouchillon, S.(1)*; Hoban, D.(1); Hackel, M.(1); Badal, R.(1); Morrissey, I.(2); Biedenbach, D.(1); Nichols, W.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

9. P1783

   Activity of ceftazidime-avibactam and comparators versus characterised class-C beta-lactamase positive Gram-negative pathogens isolated globally in the 2012 international network for optimal resistance monitoring (INFORM) programme

   Doug Biedenbach, Schaumburg, United States

   Kazmierczak, K.(1)*; Hickman, S.(1); Hackel, M.(1); Badal, R.(1); Biedenbach, D.(1); Morrissey, I.(2); Bouchillon, S.(1); Nichols, W.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

10. P1068

    Five year analysis (2009-2013) of the identification and antimicrobial susceptibility trends for Enterobacter spp. collected from EU countries in the test programme

    Doug Biedenbach, Schaumburg, United States

    Biedenbach, D.(1)*; Bouchillon, S.(1); Hackel, M.(1); Morrissey, I.(2);

    12 May 2014

    Session: Resistance surveillance in Gram-negatives

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    Poster presentation

    Bacterial Susceptibility & Resistance